Alignment Healthcare, Inc. EV/EBITDA LTM
| Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|
| EV/EBITDA LTM | (14.9x) | (16.5x) | (10.9x) |
Alignment Healthcare, Inc. (ALHC) EV/EBITDA LTM comparison analysis
General
LTM EV/EBITDA LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
ALHC key stats
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|
% growth | 757.0 0.0% | 959.2 26.7% | 1,167.8 21.7% | 1,434.2 22.8% | 1,823.6 27.2% |
| Cost of Goods Sold (COGS) | 661.4 | 793.0 | 1,039.0 | 1,249.9 | 1,622.6 |
% margin | 95.6 12.6% | 166.2 17.3% | 128.7 11.0% | 184.3 12.8% | 201.0 11.0% |
| Operating Expenses | 125.1 | 171.5 | 306.8 | 312.9 | 328.8 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 110.1 | 156.4 | 291.0 | 295.6 | 307.4 |
% margin | (29.5) (3.9%) | (6.0) (0.6%) | (178.1) (15.2%) | (128.6) (9.0%) | (127.8) (7.0%) |
| Interest Income | 14.9 | 16.9 | 17.4 | 18.3 | 0.0 |
| Interest Expense | 14.9 | 16.9 | 17.4 | 18.3 | 21.2 |
| Pre-tax Income | (44.7) | (22.9) | (195.3) | (149.3) | (148.2) |
% effective tax rate | 14.5 (32.5%) | 16.2 (70.7%) | 17.7 (9.0%) | 0.3 (0.2%) | (0.0) 0.0% |
% margin | (59.3) (7.8%) | (39.1) (4.1%) | (213.0) (18.2%) | (149.6) (10.4%) | (148.0) (8.1%) |
| EPS | (0.32) | (0.21) | (1.24) | (0.83) | (0.79) |
| Diluted EPS | (0.32) | (0.21) | (1.24) | (0.83) | (0.79) |
% margin | (13.3) (1.8%) | 9.5 1.0% | (161.8) (13.9%) | (113.5) (7.9%) | (105.3) (5.8%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Alignment Healthcare, Inc.'s EV/EBITDA LTM?
As of today, Microsoft Corp's last 12-month EV/EBITDA LTM is (20.9x), based on the financial report for Dec 30, 2024 (Q4’2024). The average annual EV/EBITDA LTM for Alignment Healthcare, Inc. have been (19.8x) over the past three years, and 0.8x over the past five years.
2) Is Alignment Healthcare, Inc.'s EV/EBITDA LTM Good?
As of today, Alignment Healthcare, Inc.'s EV/EBITDA LTM is (20.9x), which is lower than industry median of 6.7x. It indicates that Alignment Healthcare, Inc.'s EV/EBITDA LTM is Good.